Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiac and Coronary Surgery Techniques, Cardiac Valve Diseases and Treatments, Mechanical Circulatory Support Devices, and Cardiac Structural Anomalies and Repair.
A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease
Unveiling the Inflammatory Landscape of Recurrent Glioblastoma through Histological-Based Assessments.
A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
The Sledgehammer in Precision Medicine: Dexamethasone and Immunotherapeutic Treatment of Glioma.
DDDR-28. EGFR AND SRC-MEDIATED ACTIVATION OF STAT3 DRIVES RESISTANCE TO MITOTIC INHIBITORS IN GLIOBLASTOMA, AND CAN BE REVERSED WITH FDA-APPROVED DRUGS
Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series.
Protein kinase C<sub>ι</sub> and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities.
Treatment of Recurrent Glioblastoma by Chronic Convection-Enhanced Delivery of Topotecan
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series
Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience.
Biatrial maze procedure versus pulmonary vein isolation for atrial fibrillation during mitral valve surgery: New analytical approaches and end points
Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery
Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery
Costs Associated With Health Care–Associated Infections in Cardiac Surgery
Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution
Surgical Treatment of Moderate Ischemic Mitral Regurgitation
Management Practices and Major Infections After Cardiac Surgery
Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation
Blood Transfusion and Infection After Cardiac Surgery
EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure
Effects of Atrial Fibrillation on Treatment of Mitral Regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) Randomized Trial